🟢 Immunic is trading 8% up in pre-market with no clear catalyst identified

Immunic is trading at $7.80, up +8.03% in pre-market, with no clearly identified catalyst.

• Immunic announced four clinical, biomarker, and preclinical poster presentations on October 21 for a conference running October 21–23; this earlier news does not establish the cause of the gain.
• Major U.S. indices are modestly lower in the supplied market context, and the available evidence does not clearly link the gain to broad-market sentiment.
• Pre-market volume information was not available in the provided price context.